Logo image of POAI

PREDICTIVE ONCOLOGY INC (POAI) Stock Fundamental Analysis

NASDAQ:POAI - Nasdaq - US74039M3097 - Common Stock - Currency: USD

0.96  -0.03 (-3.03%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to POAI. POAI was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of POAI have multiple concerns. POAI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

POAI had negative earnings in the past year.
POAI had a negative operating cash flow in the past year.
POAI had negative earnings in each of the past 5 years.
POAI had a negative operating cash flow in each of the past 5 years.
POAI Yearly Net Income VS EBIT VS OCF VS FCFPOAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

Looking at the Return On Assets, with a value of -185.55%, POAI is doing worse than 92.55% of the companies in the same industry.
Industry RankSector Rank
ROA -185.55%
ROE N/A
ROIC N/A
ROA(3y)-150.57%
ROA(5y)-139.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
POAI Yearly ROA, ROE, ROICPOAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K -10K -15K -20K

1.3 Margins

The Gross Margin of POAI (49.08%) is comparable to the rest of the industry.
POAI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for POAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.14%
GM growth 5Y-4.67%
POAI Yearly Profit, Operating, Gross MarginsPOAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

0

2. Health

2.1 Basic Checks

POAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
POAI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, POAI has more shares outstanding
There is no outstanding debt for POAI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
POAI Yearly Shares OutstandingPOAI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
POAI Yearly Total Debt VS Total AssetsPOAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

POAI has an Altman-Z score of -48.35. This is a bad value and indicates that POAI is not financially healthy and even has some risk of bankruptcy.
POAI has a Altman-Z score of -48.35. This is amonst the worse of the industry: POAI underperforms 95.74% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -48.35
ROIC/WACCN/A
WACC9.08%
POAI Yearly LT Debt VS Equity VS FCFPOAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

POAI has a Current Ratio of 0.76. This is a bad value and indicates that POAI is not financially healthy enough and could expect problems in meeting its short term obligations.
POAI has a worse Current ratio (0.76) than 92.02% of its industry peers.
A Quick Ratio of 0.75 indicates that POAI may have some problems paying its short term obligations.
POAI has a Quick ratio of 0.75. This is amonst the worse of the industry: POAI underperforms 88.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.75
POAI Yearly Current Assets VS Current LiabilitesPOAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

POAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.28%, which is quite impressive.
POAI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.48%.
The Revenue has been growing slightly by 2.86% on average over the past years.
EPS 1Y (TTM)50.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.26%
Revenue 1Y (TTM)-31.48%
Revenue growth 3Y4.57%
Revenue growth 5Y2.86%
Sales Q2Q%-73.72%

3.2 Future

The Earnings Per Share is expected to grow by 28.66% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 158.10% on average over the next years. This is a very strong growth
EPS Next Y93.75%
EPS Next 2Y42.77%
EPS Next 3Y28.66%
EPS Next 5YN/A
Revenue Next Year569.48%
Revenue Next 2Y232.87%
Revenue Next 3Y158.1%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
POAI Yearly Revenue VS EstimatesPOAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
POAI Yearly EPS VS EstimatesPOAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

POAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
POAI is valuated reasonably with a Price/Forward Earnings ratio of 11.76.
Compared to the rest of the industry, the Price/Forward Earnings ratio of POAI indicates a rather cheap valuation: POAI is cheaper than 86.70% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of POAI to the average of the S&P500 Index (22.13), we can say POAI is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 11.76
POAI Price Earnings VS Forward Price EarningsPOAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
POAI Per share dataPOAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
POAI's earnings are expected to grow with 28.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.77%
EPS Next 3Y28.66%

More info and screens

0

5. Dividend

5.1 Amount

POAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PREDICTIVE ONCOLOGY INC

NASDAQ:POAI (6/13/2025, 8:00:01 PM)

0.96

-0.03 (-3.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-12 2025-08-12
Inst Owners2.08%
Inst Owner Change-23.31%
Ins Owners1.27%
Ins Owner Change0%
Market Cap8.57M
Analysts43.33
Price Target3.06 (218.75%)
Short Float %1.43%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-132.24%
Min EPS beat(2)-270.37%
Max EPS beat(2)5.88%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-10.68%
Min Revenue beat(2)-92.79%
Max Revenue beat(2)71.43%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.76
P/S 6.37
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.82
EYN/A
EPS(NY)0.08
Fwd EY8.5%
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS0.15
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -185.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.08%
FCFM N/A
ROA(3y)-150.57%
ROA(5y)-139.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.14%
GM growth 5Y-4.67%
F-Score3
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.25%
Cap/Sales 0.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.75
Altman-Z -48.35
F-Score3
WACC9.08%
ROIC/WACCN/A
Cap/Depr(3y)20.65%
Cap/Depr(5y)33.78%
Cap/Sales(3y)11.77%
Cap/Sales(5y)26.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.26%
EPS Next Y93.75%
EPS Next 2Y42.77%
EPS Next 3Y28.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-31.48%
Revenue growth 3Y4.57%
Revenue growth 5Y2.86%
Sales Q2Q%-73.72%
Revenue Next Year569.48%
Revenue Next 2Y232.87%
Revenue Next 3Y158.1%
Revenue Next 5YN/A
EBIT growth 1Y32.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.86%
OCF growth 3YN/A
OCF growth 5YN/A